Advertisement

Topics

Latest "Partnership to Fight Chronic Disease (PFCD)" News Stories

04:13 EST 15th December 2018 | BioPortfolio

Here are the most relevant search results for "Partnership to Fight Chronic Disease (PFCD)" found in our extensive news archives from over 250 global news sources.

More Information about Partnership to Fight Chronic Disease (PFCD) on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Partnership to Fight Chronic Disease (PFCD) for you to read. Along with our medical data and news we also list Partnership to Fight Chronic Disease (PFCD) Clinical Trials, which are updated daily. BioPortfolio also has a large database of Partnership to Fight Chronic Disease (PFCD) Companies for you to search.

Showing "Partnership Fight Chronic Disease PFCD" News Articles 1–25 of 21,000+

Saturday 15th December 2018

Vocal Cord Paralysis Global Clinical Trials Review, H2, 2018 [Report Updated: 28092018] Prices from USD $2125

Vocal Cord Paralysis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Vocal Cord Paralysis Global Clinical Trials Review, H2, 2018" provides an overview of Vocal Cord Paralysis clinical trials scenario. This report provides top line data relating to the clinical trials on Vocal Cord Paralysis. Report includes an overview of trial numbers and their average enrollmen...


Anemia in Chronic Kidney Disease Renal Anemia Global Clinical Trials Review, H1, 2018 [Report Updated: 29062018] Prices from USD $2125

Anemia in Chronic Kidney Disease Renal Anemia Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Anemia in Chronic Kidney Disease Renal Anemia Global Clinical Trials Review, H1, 2018" provides an overview of Anemia in Chronic Kidney Disease Renal Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Anemia in Chronic K...

News digest – specialist prostate cancer scans, HPV vaccine catch up, breast cancer risk and surgery gel spray 

Science blog Specialist prostate cancer MRI scans recommended on NHS A type of specialist MRI scan has been recommended as one of the first tests for diagnosing people with suspected prostate cancer. Studies have found that using mpMRI could help 1 in 4 men with an abnormal PSA test or rectal exam avoid a biopsy. And for those who did need a biopsy, the scan can help to guide the procedure, m...


Friday 14th December 2018

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Cerveau Announces Singapore Test of Neuro PET Imaging Agent

Cerveau Technologies, a partnership between Beijing Sinotau Pharma and Enigma Biomedical of Toronto, will start a Singapore trial of its PET imaging agent for neurofibrillary tangles (NFTs) in the brain, the first Asia test of the agent. Cerveau develops diagnostics and technology for neurodegenerative disorders including Alzheimer's disease. It in-licensed global rights to the agent, MK-6240, fro...

Psoriatic Arthritis Global Clinical Trials Review, H1, 2018 [Report Updated: 29062018] Prices from USD $2125

Psoriatic Arthritis Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Psoriatic Arthritis Global Clinical Trials Review, H1, 2018" provides an overview of Psoriatic Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriatic Arthritis. Report includes an overview of trial numbers and their average enrollment in...

Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase

Mutations in the gene encoding the protein kinase CDKL5 cause a debilitating neurodevelopmental disease termed CDKL5 disorder. The impact of these mutations on CDKL5 function is poorly understood because the substrates and cellular processes controlled by CDKL5 are unclear. Here, we describe a quantitative phosphoproteomic screening which identified MAP1S, CEP131 and DLG5—regulators of micro...

Traveler's Diarrhea Global Clinical Trials Review, H2, 2018 [Report Updated: 31082018] Prices from USD $2125

Traveler's Diarrhea Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Traveler's Diarrhea Global Clinical Trials Review, H2, 2018" provides an overview of Traveler's Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Traveler's Diarrhea. Report includes an overview of trial numbers and their average enrollment in...

[Comment] The changing epidemiology of mumps in a high vaccination era

The introduction of measles, mumps, and rubella (MMR) vaccine programmes has led to a dramatic reduction in all three infectious diseases globally. However, whereas measles and rubella remain under control wherever coverage is high, mumps outbreaks continue to flare up. Before universal vaccination, mumps was primarily a disease acquired during childhood and was characterised by fever and parotiti...

Drug Discovery Group encouraged by trials progress

Drug discovery group Evgen Pharma said it was delighted by progress on treatments under development when it announced its interim results for the six months to September 30 today. The AIM-listed business, which has offices in Wilmslow and Liverpool Science Park, focuses on treatments for cancer, strokes and Multiple Sclerosis. It said it released positive interim data from its ongoing clinical stu...

Celltrion Healthcare Co Ltd 091990 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryCelltrion Healthcare Co Ltd Celltrion is engaged in distributing, marketing and selling of biosimilar and biological medicines. Its products include Remsima and Truxima. Remsima is a biosimilar monoclonal antibody medication used for autoimmune diseases, including Crohn's disease CD, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis. ...

Chronic red meat consumption alters gut microbiota, raises heart disease risk.

It is known that saturated fat in red meat has long been linked to a raised risk of heart disease, and that TMAO (trimethylamine N-oxide), a gut microbiota-generated metabolite, is also linked to the pathogenesis of heart disease.  However, the link between chronic dietary patterns on TMAO production, metabolism, and renal excretion is still unclear.  Now, a study from researchers

STAT Plus: The #biotech team talks with Cecile Janssens, a research professor of epidemiology at Emory University, and asks what is a polygenic risk score and how good is it at predicting disease? https://buff.ly/2LkiLva 

STAT Plus: The #biotech team talks with Cecile Janssens, a research professor of epidemiology at Emory University, and asks what is a polygenic risk score and how good is it at predicting disease? https://buff.ly/2LkiLva 

Psychosis Global Clinical Trials Review, H1, 2018 [Report Updated: 29062018] Prices from USD $2125

Psychosis Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Psychosis Global Clinical Trials Review, H1, 2018" provides an overview of Psychosis clinical trials scenario. This report provides top line data relating to the clinical trials on Psychosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the glob...

Misinformation is the only poison: the end of the Seralini Affair? (reposted from GMOinfo.eu)

By Beat Späth, Director for Agricultural Biotechnology at EuropaBio ( Reposting of this original)“Do you remember? These spectacular images of rats with invasive cancers (…). Exhibited on television. Broadcast in film, book, resounding articles. (…) But do you know that on December 10, the journal Toxicology Sciences published o

Providence Hospital Emergency Department Remains Open and Fully Staffed, 24/7

This is to clarify a previous communication regarding Providence Hospital operations. Providence’s Emergency Care Center remains open, fully staffed, and available to serve the District of Columbia community, with the same range of services that we have always provided to support our emergency care patients, including an inpatient unit, lab, diagnostic i...

CT angiography lowers invasive testing, costs in patients with suspected CAD

Using coronary CT angiography to identify which patients with suspected coronary artery disease (CAD) really need invasive angiography can lower the overall cost of diagnostic testing without sacrificing safety, suggests a randomized trial published Dec. 12 in JACC: Cardiovascular Imaging.

Chemical Biologists Unearth Cause of Rare Brain Disorder

NewsResearchers have keyed into the biological mishap that causes stunted brain growth and muscle movement failure.

Michigan Chamber Of Commerce Successful In Fight To Improve State's Paid Sick Leave, Minimum ...

LANSING, Mich., Dec. 14, 2018 /PRNewswire/ -- The Michigan Chamber of Commerce today issued the following statement after Governor Snyder signed much-needed legislation to improve Read more...

Patients’ BMI history predicts their future CVD risk

Questioning older patients about their weight earlier in life could be a low-tech, low-cost way to better predict a person’s future risk of heart disease, according to a study published in the Journal of the American Heart Association.

Dr. Jin Kim, Internationally Influential Periodontist, Offers FDA-Cleared LANAP® Laser Therapy for Periodontal Disease in Chino Hills, CA

Board-certified periodontist Dr. Jin Y. Kim, offers minimally invasive LANAP® an FDA-cleared laser gum therapy protocol to comfortably treat patients with periodontal disease at his Chino Hills, CA, area practice. Chino Hills, CA (PRWEB) December 14, 2018 Jin Y. Kim, a leading board-certified periodontist who has dedicated his career to learning and contributing to the latest in periodontal ...

Applied Genetic Technologies Corp AGTC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryApplied Genetic Technologies Corp AGTC is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as xlinked retinoschisis, achromatopsia, xlinked retinitis pigmentosa, alpha1 antitrypsin deficiency and macular degeneration, among others. AGTC's achromatopsia prov...

Traumatic Pain Global Clinical Trials Review, H2, 2018 [Report Updated: 31082018] Prices from USD $2125

Traumatic Pain Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Traumatic Pain Global Clinical Trials Review, H2, 2018" provides an overview of Traumatic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Traumatic Pain. Report includes an overview of trial numbers and their average enrollment in top countries condu...

Post-Inflammatory Polyps Not Linked to Colorectal Neoplasia

FRIDAY, Dec. 14, 2018 -- For patients with inflammatory bowel disease (IBD), post-inflammatory polyps (PIPs) are associated with greater severity and extent of colon inflammation and higher rates of colectomy, but not with development of colorectal...

OPKO Health Inc OPK Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryOPKO Health Inc OPKO discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company's product portfolio includes pointofcare tests, laboratory developed tests LDTs, molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers its diagonostics and therapeutics that are used in the treatment of chronic kidney disease...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks